Personalized Psychiatry

<p>Preface<br>Bernhard Theodor Baune<br>1. What is personalized psychiatry and why is it necessary?<br>Bernhard Theodor Baune<br>2. The modeling of trajectories in psychotic illness<br>Scott R. Clark, Klaus Oliver Schubert, and Bernhard T. Baune<br>3. Mood trajectories as a basis for personalized psychiatry in young people<br>Klaus Oliver Schubert, Scott R. Clark, Linh K. Van, Jane L. Collinson, and Bernhard T. Baune<br>4. Transdiagnostic early intervention, prevention, and prediction in psychiatry<br>Cristina Mei, Barnaby Nelson, Jessica Hartmann, Rachael Spooner, and Patrick D. McGorry<br>5. Early intervention, prevention, and prediction in mood disorders: Tracking multidimensional outcomes in young people presenting for mental health care<br>Elizabeth M. Scott, Joanne S. Carpenter, Frank Iorfino, Shane P.M. Cross, Daniel F. Hermens, Django White, Rico S.Z. Lee, Sharon L. Naismith, Adam J. Guastella, Nicholas Glozier, F. Markus Leweke, Dagmar Koethe, Jim Lagopoulos, Jan Scott, Blake A. Hamilton, Jacob J. Crouse, Ashleigh M. Tickell, Alissa Nichles, Natalya Zmicerevska, Lillian J. Gehue, Manreena Kaur, Kate M. Chitty, and Ian B. Hickie<br>6. Consumer participation in personalized psychiatry<br>Harris A. Eyre, Elisabeth R.B. Becker, Marissa S. Blumenthal, Ajeet B. Singh, Cyrus Raji, Arshya Vahabzadeh, Zoe Wainer, and Chad Bousman<br>7. Experimental validation of psychopathology in personalized psychiatry<br>Alfons O. Hamm<br>8. Deep brain stimulation for major depression: A prototype of a personalized treatment in psychiatry<br>Thomas E. Schlaepfer and Bettina H. Bewernick<br>9. The Psychiatric Genomics Consortium: History, development, and the future<br>Hunna J. Watson, Zeynep Yilmaz and Patrick F. Sullivan<br>10. Statistical genetic concepts in psychiatric genomics<br>Darina Czamara and Divya Mehta<br>11. Opportunities and challenges of machine learning approaches for biomarker signature identification in psychiatry<br>Han Cao and Emanuel Schwarz<br>12. Personalized psychiatry with human iPSCs and neuronal reprogramming<br>Cedric Bardy, Zarina Greenberg, Seth W. Perry and Julio Licinio<br>13. Genetics of alcohol use disorder<br>Jill L. Sorcher and Falk W. Lohoff<br>14. Genomics of autism spectrum disorders<br>Margarita Raygada, Paul Grant and Owen M. Rennert<br>15. Genomics of schizophrenia<br>A. Corvin, C. Ormond and A.M. Cole<br>16. Genomics of major depressive disorder<br>Douglas F. Levinson<br>17. Personalized mental health: Artificial intelligence technologies for treatment response prediction in anxiety disorders<br>Ulrike Lueken and Tim Hahn<br>18. The genetic architecture of bipolar disorder: Entering the road of discoveries<br>Olav B. Smeland, Andreas J. Forstner, Alexander Charney, Eli A. Stahl and Ole A. Andreassen<br>19. Genomics of borderline personality disorder<br>Fabian Streit, Lucı´a Colodro-Conde, Alisha S.M. Hall and Stephanie H. Witt<br>20. Genetics of obsessive-compulsive disorder and Tourette disorder<br>Christie L. Burton, Csaba Barta, Danielle Cath, Daniel Geller, Odile A. van den Heuvel, Yin Yao, (Obsessive Compulsive Disorder and Tourette Syndrome Working Group of the Psychiatric Genomics Consortium), Valsamma Eapen, Edna Grünblatt and Gwyneth Zai<br>21. Genetics and pharmacogenetics of attention deficit hyperactivity disorder in childhood and adulthood<br>Cristian Bonvicini, Carlo Maj and Catia Scassellati<br>22. Genomics of Alzheimer’s disease<br>Margot P. van de Weijer, Iris E. Jansen, Anouk H.A. Verboven, Ole A. Andreassen and Danielle Posthuma<br>23. Current progress and future direction in the genetics of PTSD: Focus on the development and contributions of the PGC-PTSD working group<br>Angela G. Junglen, Christina Sheerin, Douglas L. Delahanty, Michael A. Hauser, Adriana Lori, Rajendra A. Morey, Caroline M. Nievergelt, Nicole R. Nugent, Jonathan Sebat, Alicia K. Smith, Jennifer A. Sumner, Monica Uddin and Ananda B. Amstadter<br>24. Genomic contributions to anxiety disorders<br>Shareefa Dalvie, Nastassja Koen and Dan J. Stein<br>25. Proteomics for diagnostic and therapeutic blood biomarker discovery in schizophrenia and other psychotic disorders<br>David R. Cotter, Sophie Sabherwal and Klaus Oliver Schubert<br>26. Molecular biomarkers in depression: Toward personalized psychiatric treatment<br>Anand Gururajan, John F Cryan and Timothy G Dinan<br>27. Neuroimaging biomarkers of late-life major depressive disorder pathophysiology, pathogenesis, and treatment response<br>Helmet T. Karim, Charles F. Reynolds, III and Stephen F. Smagula<br>28. Copy number variants in psychiatric disorders<br>Franziska Degenhardt<br>29. Gene-environment interaction in psychiatry<br>Hans Jörgen Grabe and Sandra Van der Auwera<br>30. Epigenetics: A new approach to understanding mechanisms in depression and to predict antidepressant treatment response<br>Helge Frieling, Stefan Bleich and Alexandra Neyazi<br>31. Gene coexpression network and machine learning in personalized psychiatry<br>Liliana G. Ciobanu, Micah Cearns and Bernhard T. Baune<br>32. Pharmacogenomics of bipolar disorder<br>Claudia Pisanu, Alessio Squassina, Martin Alda and Giovanni Severino<br>33. Pharmacogenomics of treatment response in major depressive disorder<br>Joanna M. Biernacka, Ahmed T. Ahmed, Balwinder Singh and Mark A. Frye<br>34. Genomic treatment response prediction in schizophrenia<br>Sophie E. Legge, Antonio F. Pardiñas and James T.R. Walters　<br>35. Personalized treatment in bipolar disorder<br>Estela Salagre, Eduard Vieta and Iria Grande<br>36. Genetic testing in psychiatry: State of the evidence<br>Chad A. Bousman, Lisa C. Brown, Ajeet B. Singh, Harris A. Eyre and Daniel J. Müller<br>37. Opportunities and challenges of implementation models of pharmacogenomics in clinical practice<br>Jonathan C.W. Liu, Ilona Gorbovskaya, Chad Bousman, Lisa C. Brown and Daniel J. Müller<br>38. Metabolomics in psychiatry<br>Renee-Marie Ragguett and Roger S. McIntyre<br>39. Real-time fMRI brain-computer interface: A tool for personalized psychiatry?<br>David E.J. Linden<br>40. How functional neuroimaging can be used for prediction and evaluation in psychiatry<br>Beata R. Godlewska and Catherine J. Harmer<br>41. Neuroimaging, genetics, and personalized psychiatry: Developments and opportunities from the ENIGMA consortium<br>Lianne Schmaal, Christopher R.K. Ching, Agnes B. McMahon, Neda Jahanshad and Paul M. Thompson<br>42. Applying a neural circuit taxonomy in depression and anxiety for personalized psychiatry<br>Leanne M. Williams and Andrea N. Goldstein-Piekarski<br>43. Multimodal modeling for personalized psychiatry<br>Scott R. Clark, Micah Cearns, Klaus Oliver Schubert and Bernhard T. Baune<br>44. Standardized biomarker and biobanking requirements for personalized psychiatry<br>Catherine Toben, Victoria K. Arnet, Anita Lo, Pamela H. Saunders and Bernhard T. Baune<br>45. Ethical, policy, and research considerations for personalized psychiatry<br>Ryan Abbott, Donald D. Chang and Harris A. Eyre<br>46. The future of personalized psychiatry<br>Bernhard T. Baune</p>